{
    "nctId": "NCT05397457",
    "briefTitle": "Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia",
    "officialTitle": "Effect of Helmet Type, Home-use Photobiomodulation Therapy Device for Chemotherapy-induced Alopecia",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Chemotherapy-induced Alopecia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 106,
    "primaryOutcomeMeasure": "Hair counts recorded by Sentra scalp analyzer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age: 20 to 75 years\n* Informed Consent as documented by signature.\n* Able to read and converse in chinese\n* Female\n* Diagnosis of breast cancer\n* They completed chemotherapy no more than 2 weeks\n* Treatment with neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy: anthracycline and taxane containing (paclitaxel or docetaxel) chemotherapy regimen.\n* life expectancy was at least 6 months.\n* Diagnosed with CIA grade 2 according to Common Terminology Criteria for Adverse Events (CTCAE)\n\nExclusion Criteria:\n\n* scalp tumor or melanoma\n* having any serious mental illness or history, or taking psychotropic drugs\n* a medical history of dermatosis\n* severe liver and kidney damage\n* Pregnancy\n* Take any of the following medications for 6 months prior to initiation of the study: topical minoxidil, and spironolactone, and topical calcitriol\n* Receiving scalp cooling during chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}